| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Cxcl10 ELISA kit; Crg2 ELISA kit; Ifi10 ELISA kit; Inp10 ELISA kit; Scyb10C-X-C motif chemokine 10 ELISA kit; 10 kDa interferon gamma-induced protein ELISA kit; Gamma-IP10 ELISA kit; IP-10 ELISA kit; C7 ELISA kit; Interferon-gamma induced protein CRG-2 ELISA kit; Small-inducible cytokine B10 ELISA kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
interferon-inducible protein 10 (CXCL10) is a biological molecule commonly studied in immunology research. It is often studied in the context of chemokine-driven cell trafficking and inflammatory communication.
UniProt: P17515
Biological context
Researchers often monitor interferon-inducible protein 10 in serum, plasma, and tissue homogenates to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in interferon-inducible protein 10 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, interferon-inducible protein 10 may also appear under names such as Cxcl10 and Crg2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that interferon-inducible protein 10 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
CRTC1 enhances PD-L1-mediated tumor immunosuppression in non-small cell lung cancer via the Notch1/Akt signaling pathway
X Feng, Y Shi, F Yuan, Y Hu, X Tang, W Zhang,Frontiers in Immunology,2025
Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration
L Gan, T Lu, Y Lu, H Song, J Zhang, K Zhang,Journal for ImmunoTherapy of Cancer,2024
Exercise accelerates recruitment of CD8+ T cell to promotes anti-tumor immunity in lung cancer via epinephrine
SN Miao,BMC cancer,2024
Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy
X Qin,Bioactive materials,2024
MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10
C Peng,Cell death & disease,2023
The Chemokine Receptor CXCR3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells
Qing-Zhi Liu.et al,Front. Immunol.,2018
Enhancement of Lipid Metabolism and Hepatic Stability in Fat-Induced Obese Mice by Fermented Cucurbita moschata Extract
Md. Akil Hossain.et al,Evidence-Based Complementary and Alternative Medicine 2018,2018